Skip to main content
. 2016 Aug 1;7(37):59834–59844. doi: 10.18632/oncotarget.10975

Figure 4. Shortening and lengthening patterns for the 3′UTR markers, patient outcomes and risk scores.

Figure 4

Risk groups were defined by the risk score with the most significant (log-rank test) split of the training samples.